D-0385-2026 Class II Ongoing

Recalled by HTO Nevada Inc. Dba Kirkman — Lake Oswego, OR

FDA drug recall D-0385-2026 was initiated by HTO Nevada Inc. Dba Kirkman on Feb 18, 2026 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry Date. The recall status is ongoing. Affected quantity: 27,380 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 11, 2026
Initiation Date
Feb 18, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27,380 bottles.

Product description

FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.

Reason for recall

Stability Data Does Not Support Expiry Date.

Distribution pattern

Nationwide within the U.S

Code information

Lot #: 839CP-0016, Exp. Date 03/31/2026; 839CP-0017, Exp. Date 06/30/2026; 839CP-0018, Exp. Date 08/31/2026; 839CP-0019, Exp. Date 10/31/2026; 839CP-0020, Exp. Date 03/31/2027; 839CP-0021, Exp. Date 07/31/2027; 839CP-0022, Exp.Date 11/30/2027; 839CP-0023, Exp. Date 02/29/2028; 839CP-0024, Exp. Date 07/31/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0385-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0385-2026. Report a data issue: hello@regdatalab.com.